What are Rein Therapeutics, Inc. Common Stock's total assets?

Rein Therapeutics, Inc. Common Stock (RNTX) holds $26.3M in total assets, down 54.4% year over year.

How much cash does Rein Therapeutics, Inc. Common Stock have?

Rein Therapeutics, Inc. Common Stock holds $4.4M in cash and equivalents.

Can Rein Therapeutics, Inc. Common Stock cover its short-term obligations?

Its current ratio is 0.40 — current liabilities exceed current assets.

Where does Rein Therapeutics, Inc. Common Stock's balance sheet data come from?

Every line is extracted from Rein Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Rein Therapeutics, Inc. Common Stock RNTX Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$3.22M-75.0%	$12.87M-25.8%	$17.34M+234%	$5.19M+44.3%
Prepaid expenses and other current assets	$1.11M+40.3%	$792K-10.2%	$882K+45.5%	$606K-72.7%
Total current assets	$4.33M-68.3%	$13.66M-25.2%	$18.27M-16.5%	$21.87M-54.6%
Property and equipment, net	$0-100%	$1K-94.7%	$19K-72.9%	$70K-45.3%
Goodwill	$6.33M0.0%	$6.33M0.0%	$6.33M—	——
Intangible assets, net	$13.5M-68.0%	$42.2M-46.7%	$79.2M—	——
Deferred tax assets	$1.06M-40.2%	$1.77M-46.7%	$3.33M—	——
Other non-current assets	$2K0.0%	$2K-99.9%	$2.19M+9,038%	$24K0.0%
Total assets	$24.16M-61.2%	$62.19M-41.3%	$106.01M+382%	$22.01M-54.6%
Accounts payable	$3.98M+336%	$911K-23.4%	$1.19M-30.8%	$1.72M+42.1%
Accrued expenses	$2.2M-54.4%	$4.84M+53.7%	$3.15M+92.9%	$1.63M-49.1%
Total current liabilities	$6.18M+7.5%	$5.75M+31.1%	$4.39M+29.6%	$3.38M-24.9%
Other non-current liabilities	$0-100%	$277K—	——	——
Total liabilities	$7.24M-7.2%	$7.8M+1.1%	$7.71M+128%	$3.38M-26.1%
Common stock	$113K+4.6%	$108K+18.7%	$91K0.0%	$91K0.0%
Additional paid-in capital	$373.13M+3.4%	$360.7M+22.1%	$295.38M+1.4%	$291.37M+0.7%
Retained earnings	-$401.27M-14.2%	-$351.4M-21.8%	-$288.52M-5.8%	-$272.79M-11.1%
Accumulated other comprehensive income (loss)	-$62K-244%	-$18K+71.4%	-$63K-31.3%	-$48K-269%
Total liabilities and stockholders' equity	$24.16M-61.2%	$62.19M-41.3%	$106.01M+382%	$22.01M-54.6%
Deferred Tax Assets and Other Non-Current Assets	$2K0.0%	$2K-99.9%	$2.19M+9,038%	$24K0.0%
Other intangible assets—net	$13.5M-68.0%	$42.2M-46.7%	$79.2M—	——
Other non-current assets	$2K0.0%	$2K-99.9%	$2.19M+9,038%	$24K0.0%
Software and Technology Licenses, Net	$2K0.0%	$2K-99.9%	$2.19M+9,038%	$24K0.0%
Notes Payable Current	$0—	——	——	——
Notes Payable	$0—	——	——	——
Accrued expenses and other liabilities	$2.2M-54.4%	$4.84M+53.7%	$3.15M+92.9%	$1.63M-49.1%
Additional paid-in capital	$373.13M+3.4%	$360.7M+22.1%	$295.38M+1.4%	$291.37M+0.7%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$113K+4.6%	$108K+18.7%	$91K0.0%	$91K0.0%
Deferred income taxes	$1.06M-40.2%	$1.77M-46.7%	$3.33M—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Rein Therapeutics, Inc. Common Stock's total assets?: Rein Therapeutics, Inc. Common Stock (RNTX) holds $26.3M in total assets, down 54.4% year over year.
How much cash does Rein Therapeutics, Inc. Common Stock have?: Rein Therapeutics, Inc. Common Stock holds $4.4M in cash and equivalents.
Can Rein Therapeutics, Inc. Common Stock cover its short-term obligations?: Its current ratio is 0.40 — current liabilities exceed current assets.
Where does Rein Therapeutics, Inc. Common Stock's balance sheet data come from?: Every line is extracted from Rein Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.